SPP1 and triple-A syndrome: Western blot analyses and immunofluorescence staining showed that colchicine treatment increased the expression of α-SMA (a marker of VSMCs contractile phenotype) and suppressed the expression of OPN (a marker of VSMCs synthetic phenotype) after AAA induction (Figure 2A,B).